SAB BIOTHERAPEUTICS, INC. Interest Income, Other
SAB BIOTHERAPEUTICS, INC. (SABS) reported Interest Income, Other of $1.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-08-06
- SAB BIOTHERAPEUTICS, INC. interest income, other for the quarter ending 2026-06-30 was $1.71M, a 12107.14% increase year-over-year.
- SAB BIOTHERAPEUTICS, INC. interest income, other for the quarter ending 2026-03-31 was $1.05M, a 1575.57% increase year-over-year.
- SAB BIOTHERAPEUTICS, INC. interest income, other for the quarter ending 2025-12-31 was $700.74K, a 413.84% increase year-over-year.
- SAB BIOTHERAPEUTICS, INC. interest income, other for the quarter ending 2025-09-30 was $655.23K, a 136.40% increase year-over-year.
- SAB BIOTHERAPEUTICS, INC. interest income, other for fiscal 2025 was $1.43M, a 11.36% increase from fiscal 2024.
- SAB BIOTHERAPEUTICS, INC. interest income, other for fiscal 2024 was $1.29M, a 119.84% increase from fiscal 2023.
- SAB BIOTHERAPEUTICS, INC. interest income, other for fiscal 2023 was $584.97K, a 723.06% increase from fiscal 2022.
- SAB BIOTHERAPEUTICS, INC. interest income, other for fiscal 2022 was $71.07K, a 207.47% increase from fiscal 2021.
| Period end | Interest Income, Other 3 month | Interest Income, Other 3 month as first filed | Interest Income, Other 6 month | Interest Income, Other 6 month as first filed | Interest Income, Other 9 month | Interest Income, Other 9 month as first filed | Interest Income, Other 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.71M 10-Q · filed 2026-08-06 | $2.76M 10-Q · filed 2026-08-06 | $3.46M derived: sum of 3 quarters · filed 2026-08-06 | $4.11M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $1.05M 10-Q · filed 2026-05-12 | $1.75M derived: sum of 2 quarters · filed 2026-05-12 | $2.40M derived: sum of 3 quarters · filed 2026-05-12 | $2.42M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $700.74K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.36M derived: sum of 2 quarters · filed 2026-03-09 | $1.37M derived: sum of 3 quarters · filed 2026-08-06 | $1.43M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $655.23K 10-Q · filed 2025-11-14 | $669.23K derived: sum of 2 quarters · filed 2026-08-06 | $731.29K 10-Q · filed 2025-11-14 | $868.11K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $14.00K 10-Q · filed 2026-08-06 | $13.56K 10-Q · filed 2025-08-07 | $76.00K 10-Q · filed 2026-08-06 | $76.06K 10-Q · filed 2025-08-07 | $212.87K derived: sum of 3 quarters · filed 2026-08-06 | $490.05K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $62.50K 10-Q · filed 2026-05-12 | $198.87K derived: sum of 2 quarters · filed 2026-05-12 | $476.05K derived: sum of 3 quarters · filed 2026-05-12 | $850.60K derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | $136.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $413.55K derived: sum of 2 quarters · filed 2026-03-09 | $788.11K derived: sum of 3 quarters · filed 2026-03-09 | $1.29M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $277.17K 10-Q · filed 2025-11-14 | $651.73K derived: sum of 2 quarters · filed 2025-11-14 | $1.15M 10-Q · filed 2025-11-14 | $1.63M derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $374.56K 10-Q · filed 2025-08-07 | $872.45K 10-Q · filed 2025-08-07 | $1.36M derived: sum of 3 quarters · filed 2025-08-07 | $1.37M derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $497.89K 10-Q · filed 2025-05-09 | $981.94K derived: sum of 2 quarters · filed 2025-05-09 | $996.30K derived: sum of 3 quarters · filed 2025-05-09 | $1.02M derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | $484.05K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $498.41K derived: sum of 2 quarters · filed 2025-03-31 | $526.98K derived: sum of 3 quarters · filed 2025-03-31 | $584.97K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $14.36K 10-Q · filed 2024-11-06 | $42.93K derived: sum of 2 quarters · filed 2024-11-06 | $100.92K 10-Q · filed 2024-11-06 | $130.85K derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $28.57K 10-Q · filed 2024-08-08 | $86.56K 10-Q · filed 2024-08-08 | $116.48K derived: sum of 3 quarters · filed 2024-08-08 | $133.87K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $57.99K 10-Q · filed 2024-05-20 | $87.92K derived: sum of 2 quarters · filed 2024-05-20 | $105.30K derived: sum of 3 quarters · filed 2024-05-20 | $121.13K derived: sum of 4 quarters · filed 2024-05-20 | |||
| 2022-12-31 | $29.93K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $47.31K derived: sum of 2 quarters · filed 2024-03-29 | $63.14K derived: sum of 3 quarters · filed 2024-03-29 | $71.07K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $17.39K 10-Q · filed 2023-11-13 | $33.21K derived: sum of 2 quarters · filed 2023-11-13 | $41.14K 10-Q · filed 2023-11-13 | $49.69K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $15.82K 10-Q · filed 2023-08-21 | $23.76K 10-Q · filed 2023-08-21 | $32.30K derived: sum of 3 quarters · filed 2023-08-21 | $36.07K derived: sum of 4 quarters · filed 2023-08-21 | |||
| 2022-03-31 | $7.93K 10-Q · filed 2023-05-15 | $16.48K derived: sum of 2 quarters · filed 2023-05-15 | $20.25K derived: sum of 3 quarters · filed 2023-05-15 | $25.54K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $8.54K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-04-28 | $12.31K derived: sum of 2 quarters · filed 2023-04-28 | $17.61K derived: sum of 3 quarters · filed 2023-04-28 | $23.11K 10-K/A · filed 2023-04-28 | |||
| 2021-09-30 | $3.77K 10-Q · filed 2022-11-14 | $2.93K 10-Q · filed 2021-11-22 | $9.06K derived: sum of 2 quarters · filed 2022-11-14 | $14.57K 10-Q · filed 2022-11-14 | $8.24K 10-Q · filed 2021-11-22 | ||
| 2021-06-30 | $5.30K 10-Q · filed 2022-08-10 | $10.80K 10-Q · filed 2022-08-10 | |||||
| 2021-03-31 | $5.51K 10-Q · filed 2022-05-12 | ||||||
| 2020-12-31 | $26.13K 10-K/A · filed 2023-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |